|
Records |
Links |
|
Author |
Shcheglovitov, A.; Shcheglovitova, O.; Yazawa, M.; Portmann, T.; Shu, R.; Sebastiano, V.; Krawisz, A.; Froehlich, W.; Bernstein, J.A.; Hallmayer, J.F.; Dolmetsch, R.E. |

|
|
Title |
SHANK3 and IGF1 restore synaptic deficits in neurons from 22q13 deletion syndrome patients |
Type |
Journal Article |
|
Year |
2013 |
Publication |
Nature |
Abbreviated Journal |
Nature |
|
|
Volume  |
503 |
Issue |
7475 |
Pages |
267-271 |
|
|
Keywords |
Cell Line; Child; Chromosome Deletion; Chromosome Disorders/genetics/*physiopathology; Chromosomes, Human, Pair 22/genetics; Female; GABA Agents/pharmacology; Gene Expression Regulation/drug effects; Humans; Insulin-Like Growth Factor I/*pharmacology; Lentivirus/genetics; Male; Nerve Tissue Proteins/*genetics/*metabolism; Neurons/cytology/drug effects/*physiology; Pluripotent Stem Cells/cytology; Receptors, Glutamate/genetics; Sequence Deletion; Synapses/*drug effects/genetics/*physiology; Synaptic Transmission/drug effects/genetics |
|
|
Abstract |
Phelan-McDermid syndrome (PMDS) is a complex neurodevelopmental disorder characterized by global developmental delay, severely impaired speech, intellectual disability, and an increased risk of autism spectrum disorders (ASDs). PMDS is caused by heterozygous deletions of chromosome 22q13.3. Among the genes in the deleted region is SHANK3, which encodes a protein in the postsynaptic density (PSD). Rare mutations in SHANK3 have been associated with idiopathic ASDs, non-syndromic intellectual disability, and schizophrenia. Although SHANK3 is considered to be the most likely candidate gene for the neurological abnormalities in PMDS patients, the cellular and molecular phenotypes associated with this syndrome in human neurons are unknown. We generated induced pluripotent stem (iPS) cells from individuals with PMDS and autism and used them to produce functional neurons. We show that PMDS neurons have reduced SHANK3 expression and major defects in excitatory, but not inhibitory, synaptic transmission. Excitatory synaptic transmission in PMDS neurons can be corrected by restoring SHANK3 expression or by treating neurons with insulin-like growth factor 1 (IGF1). IGF1 treatment promotes formation of mature excitatory synapses that lack SHANK3 but contain PSD95 and N-methyl-D-aspartate (NMDA) receptors with fast deactivation kinetics. Our findings provide direct evidence for a disruption in the ratio of cellular excitation and inhibition in PMDS neurons, and point to a molecular pathway that can be recruited to restore it. |
|
|
Address |
Department of Neurobiology, Stanford University, Stanford, California 94305, USA |
|
|
Corporate Author |
|
Thesis |
|
|
|
Publisher |
|
Place of Publication |
|
Editor |
|
|
|
Language |
English |
Summary Language |
|
Original Title |
|
|
|
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
|
Series Volume |
|
Series Issue |
|
Edition |
|
|
|
ISSN |
0028-0836 |
ISBN |
|
Medium |
|
|
|
Area |
|
Expedition |
|
Conference |
|
|
|
Notes |
PMID:24132240 |
Approved |
no |
|
|
Call Number |
refbase @ user @ |
Serial |
16867 |
|
Permanent link to this record |
|
|
|
|
Author |
King, I.F.; Yandava, C.N.; Mabb, A.M.; Hsiao, J.S.; Huang, H.-S.; Pearson, B.L.; Calabrese, J.M.; Starmer, J.; Parker, J.S.; Magnuson, T.; Chamberlain, S.J.; Philpot, B.D.; Zylka, M.J. |

|
|
Title |
Topoisomerases facilitate transcription of long genes linked to autism |
Type |
Journal Article |
|
Year |
2013 |
Publication |
Nature |
Abbreviated Journal |
Nature |
|
|
Volume  |
501 |
Issue |
7465 |
Pages |
58-62 |
|
|
Keywords |
Animals; Autistic Disorder/*genetics; DNA Topoisomerases, Type I/deficiency/*metabolism; DNA Topoisomerases, Type II/deficiency/metabolism; DNA-Binding Proteins/antagonists & inhibitors/deficiency/metabolism; Gene Knockdown Techniques; Genomic Imprinting/genetics; Humans; Mice; Mutation/genetics; RNA Polymerase II/metabolism; Synapses/metabolism; Topoisomerase Inhibitors/pharmacology; Topotecan/pharmacology; *Transcription Elongation, Genetic/drug effects |
|
|
Abstract |
Topoisomerases are expressed throughout the developing and adult brain and are mutated in some individuals with autism spectrum disorder (ASD). However, how topoisomerases are mechanistically connected to ASD is unknown. Here we find that topotecan, a topoisomerase 1 (TOP1) inhibitor, dose-dependently reduces the expression of extremely long genes in mouse and human neurons, including nearly all genes that are longer than 200 kilobases. Expression of long genes is also reduced after knockdown of Top1 or Top2b in neurons, highlighting that both enzymes are required for full expression of long genes. By mapping RNA polymerase II density genome-wide in neurons, we found that this length-dependent effect on gene expression was due to impaired transcription elongation. Interestingly, many high-confidence ASD candidate genes are exceptionally long and were reduced in expression after TOP1 inhibition. Our findings suggest that chemicals and genetic mutations that impair topoisomerases could commonly contribute to ASD and other neurodevelopmental disorders. |
|
|
Address |
Department of Cell Biology and Physiology, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA |
|
|
Corporate Author |
|
Thesis |
|
|
|
Publisher |
|
Place of Publication |
|
Editor |
|
|
|
Language |
English |
Summary Language |
|
Original Title |
|
|
|
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
|
Series Volume |
|
Series Issue |
|
Edition |
|
|
|
ISSN |
0028-0836 |
ISBN |
|
Medium |
|
|
|
Area |
|
Expedition |
|
Conference |
|
|
|
Notes |
PMID:23995680; PMCID:PMC3767287 |
Approved |
no |
|
|
Call Number |
refbase @ user @ |
Serial |
16875 |
|
Permanent link to this record |
|
|
|
|
Author |
Wu, Y.; Koschan, M.; Li, Q.; Greeley, I.; Melcher, C.L. |
|
|
Title |
Revealing the role of calcium codoping on optical and scintillation homogeneity in Lu2SiO5:Ce single crystals |
Type |
Journal Article |
|
Year |
2018 |
Publication |
J. Cryst. Growth |
Abbreviated Journal |
|
|
|
Volume  |
498 |
Issue |
|
Pages |
362 |
|
|
Keywords |
|
|
|
Abstract |
|
|
|
Address |
|
|
|
Corporate Author |
|
Thesis |
|
|
|
Publisher |
|
Place of Publication |
|
Editor |
|
|
|
Language |
|
Summary Language |
|
Original Title |
|
|
|
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
|
Series Volume |
|
Series Issue |
|
Edition |
|
|
|
ISSN |
|
ISBN |
|
Medium |
|
|
|
Area |
|
Expedition |
|
Conference |
|
|
|
Notes |
|
Approved |
no |
|
|
Call Number |
refbase @ user @ |
Serial |
17761 |
|
Permanent link to this record |
|
|
|
|
Author |
"Hooper, W.L. & W., Roy T." |
|
|
Title |
Electrical problems : for engineering students |
Type |
Book Whole |
|
Year |
1902 |
Publication |
|
Abbreviated Journal |
|
|
|
Volume  |
000477 |
Issue |
|
Pages |
170p |
|
|
Keywords |
|
|
|
Abstract |
|
|
|
Address |
|
|
|
Corporate Author |
|
Thesis |
|
|
|
Publisher |
"Ginn And Company, Boston" |
Place of Publication |
|
Editor |
|
|
|
Language |
|
Summary Language |
|
Original Title |
|
|
|
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
|
Series Volume |
|
Series Issue |
|
Edition |
|
|
|
ISSN |
|
ISBN |
|
Medium |
|
|
|
Area |
|
Expedition |
|
Conference |
|
|
|
Notes |
|
Approved |
no |
|
|
Call Number |
refbase @ user @ 408 |
Serial |
12803 |
|
Permanent link to this record |
|
|
|
|
Author |
Yazawa, M.; Hsueh, B.; Jia, X.; Pasca, A.M.; Bernstein, J.A.; Hallmayer, J.; Dolmetsch, R.E. |

|
|
Title |
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome |
Type |
Journal Article |
|
Year |
2011 |
Publication |
Nature |
Abbreviated Journal |
Nature |
|
|
Volume  |
471 |
Issue |
7337 |
Pages |
230-234 |
|
|
Keywords |
Action Potentials/drug effects; Autistic Disorder; Calcium Channels, L-Type/genetics/metabolism; Calcium Signaling/drug effects; Cell Transdifferentiation; Cellular Reprogramming/genetics; Drug Evaluation, Preclinical/*methods; Fibroblasts/cytology; HEK293 Cells; Humans; Induced Pluripotent Stem Cells/*pathology; Long QT Syndrome/drug therapy/genetics/metabolism/pathology; Mutation, Missense/genetics; Myocytes, Cardiac/*drug effects/metabolism/*pathology; Patch-Clamp Techniques; Phenotype; Purines/pharmacology; Single-Cell Analysis; Syndactyly/drug therapy/genetics/metabolism/pathology |
|
|
Abstract |
Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia. LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors. A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome. To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca(2+)) imaging studies of these cells revealed irregular contraction, excess Ca(2+) influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca(2+) signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases. |
|
|
Address |
Department of Neurobiology, Stanford University School of Medicine, Stanford, California 94305, USA |
|
|
Corporate Author |
|
Thesis |
|
|
|
Publisher |
|
Place of Publication |
|
Editor |
|
|
|
Language |
English |
Summary Language |
|
Original Title |
|
|
|
Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
|
|
Series Volume |
|
Series Issue |
|
Edition |
|
|
|
ISSN |
0028-0836 |
ISBN |
|
Medium |
|
|
|
Area |
|
Expedition |
|
Conference |
|
|
|
Notes |
PMID:21307850; PMCID:PMC3077925 |
Approved |
no |
|
|
Call Number |
refbase @ user @ |
Serial |
16987 |
|
Permanent link to this record |